Successful FDA Inspection of Our Clinical Pharmacology Unit

Last year, our Clinical Pharmacology Unit in Rennes underwent a successful inspection by the FDA as part of its Bioresearch Monitoring Program. This program is designed to ensure the data and information submitted to the FDA are scientifically valid and reliable; and that the rights, welfare, and safety of research subjects are protected during the study of an investigational product.

For our Clinical Pharmacology Unit, passing the FDA inspection is a testament to the hard work and dedication of our team. We are committed to conducting research that meets the highest scientific and ethical standards, and we are proud to have our efforts recognized by the FDA. We look forward to continuing to contribute to the development of safe and effective medical products.